“…In a pooled analysis of eight large North American prospective studies that involved 9167 participants with a median follow-up of 47.2 months, the incidence of interval cancer was low (0.6%, or 1.71 per 1000 person-years of follow-up) (24). However, assuming that the incidence of new cases of CRC is approximately 1,000,000 per year worldwide and considering that 1 of 30 diagnosed CRCs is an interval cancer, the occurrence of >30,000 interval cancers might be annually expected (9). In both our study and a prior Japanese multicenter retrospective study (17), the incidences of PCCRC were lower (1.5% and 0.55%, respectively) compared with those in Western studies.…”